NPRA evaluating Sinovac vaccine for young children

The National Pharmaceutical Regulator Agency (NPRA) is evaluating the use of Sinovac’s Covid-19 vaccine for use on children below 12 years old.

According to its director Roshayati Mohd Sani, the agency had just received the dossier on the vaccine’s use for this age group last week.

“We are still...